Before today's opening bell, the St. Louis-based agricultural products company reported earnings of 7 cents per diluted share, while analysts were expecting a loss of 2 cents per share.
Revenue for the period was $2.56 billion, above Wall Street's projections of $2.36 billion.
"Despite challenges to our business in fiscal year 2016, we delivered on the drivers that position Monsanto for the return to EPS growth in the year ahead," CEO Hugh Grant said in a statement.
Last month, the company accepted a $66 billion takeover offer from German chemical company Bayer (BAYRY).
Grant said Monsanto will execute the "necessary steps" to close the deal with Bayer.
"Ultimately, we believe that combining with Bayer represents the most compelling value for our shareowners, with the most certainty through the all-cash consideration," he said.
Separately, TheStreet Ratings Team has a "Hold" rating with a score of C+ on the stock.
The primary factors that have impacted the rating are mixed. The company's strengths can be seen in multiple areas, such as its good cash flow from operations, expanding profit margins and solid stock price performance.
But the team also finds weaknesses including feeble growth in the company's earnings per share, deteriorating net income and generally higher debt management risk.
Recently, TheStreet Ratings objectively rated this stock according to its "risk-adjusted" total return prospect over a 12-month investment horizon. Not based on the news in any given day, the rating may differ from Jim Cramer's view or that of this articles's author.
You can view the full analysis from the report here: MON